Prescription medications can ease overactive bladder symptoms. Supplements for overactive bladder may help, although little robust evidence supports their value. An overactive bladder (OAB ...

The Oxytrol for Women (oxybutynin) patch is available without a prescription to treat those with an overactive bladder, which can cause incontinence problems and make women run to the bathroom ...

Other prescription treatment options include ... When this happens, symptoms associated with overactive bladder are reduced.

The Oxytrol for Women patch, available only with a prescription until 2013, is now OTC. But our medical experts caution against treating yourself for an overactive bladder without a diagnosis.

Botox is a prescription drug that’s used to treat certain bladder problems, such as overactive bladder (OAB) in adults. For certain bladder problems, Botox may also be prescribed to children ...

Overactive bladder is a well established and bothersome clinical condition for which antimuscarinic drugs are the treatment of choice. Oxybutynin, the longest established antimuscarinic, is a ...

Simple lifestyle and diet changes can really help you successfully manage overactive bladder. Managing a full and busy work day can be a challenge for those with OAB, but with a few well-planned ...

Gemtesa (vibegron) is a prescription drug used to treat symptoms of overactive bladder (OAB). Gemtesa can cause side effects that range from mild to serious. Examples include headache, nausea ...

The updated prescription information on Tolterodine ... It is prescribed for the treatment of overactive bladder with symptoms of urinary incontinence, urgency and frequency.

The prescription products were categorized ... hypercholesterolemia, migraine, overactive bladder, and osteoporosis. A total of 31 products were advertised directly to consumers for the eight ...

Jason Whiting, with more than 25 years' experience in medical technology, steps in as CEO of Avation Medical Inc. He succeeds co-founder Jill Schiaparelli, who led the company since 2018, starting ...